Key result
Current treatments for chronic heart failure in children are extrapolated from adult studies, highlighting the need for prospective, randomized trials specifically in pediatric populations.
Why the study?
What is the current state of evidence for treating chronic congestive heart failure in children?
What is the current state of evidence for treating chronic congestive heart failure in children?
Answers are grounded in this paper and cite their sources.
This review emphasizes the critical need for pediatric-specific randomized trials for heart failure therapies, as current practices rely heavily on adult data.
Treatment strategies for chronic heart failure in children have generally been extrapolated from studies in adults with heart failure. This presentation reviews the existing knowledge and recommendations regarding the treatment of chronic heart failure in adults and the information that is available in children. Medications currently recommended for use in adults include diuretics, digoxin, angiotensin-converting enzyme inhibitors, and beta-blockers. These recommendations are based on results from large, randomized, multicenter trials. Anecdotal evidence suggests similar beneficial effects of these medications in children. The fact that the etiologies, pathophysiology, and physiologic consequences of heart failure in children often differ greatly from those in adults, however, justifies the development of prospective, randomized trials to evaluate these medications specifically in children. Findings from these types of studies will provide critical information for developing guidelines for the appropriate treatment of children with chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Robert E. Shaddy (2001) conducted a review in chronic congestive heart failure. Heart failure medications (diuretics, digoxin, ACE inhibitors, beta-blockers) was evaluated. Current treatments for chronic heart failure in children are extrapolated from adult studies, highlighting the need for prospective, randomized trials specifically in pediatric populations.
Synapse has enriched 10 related papers. Consider them for comparative context: